This was expected as the PC3 prostate cancer line has high expression of CD13, making it an ideal therapeutic target for NGR-directed delivery of truncated coagulase to efficiently induce thrombosis, reduce tumor cell proliferation and increase cell death in these highly aggressive and widely used human tumor cell line models. Here, ANPEP is linked to neoplasm.